UPENDRA S DHANJAL

Allopathic & Osteopathic Physicians|Internal Medicine|Pulmonary Disease SOMERS POINT, NJ NPI 1831152404

General Payments — all program years on this page

$961.50

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 54
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $346.46 across 20 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $346.4620

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $174.319
2019 $129.617
2020 $42.453
2022 $29.622
2023 $239.0513
2024 $346.4620

Records — PY2024 (20)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1104325458 AstraZeneca Pharmaceuticals LP $13.47 04/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104356567 AstraZeneca Pharmaceuticals LP $14.50 02/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104360649 AstraZeneca Pharmaceuticals LP $14.71 08/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104670025 AstraZeneca Pharmaceuticals LP $20.45 05/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114036967 Regeneron Healthcare Solutions, Inc. $19.76 07/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114036969 Regeneron Healthcare Solutions, Inc. $16.88 10/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116261343 GlaxoSmithKline, LLC. $16.77 09/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120648951 Baxter Healthcare $23.28 01/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1123380632 Avadel CNS Pharmaceuticals, LLC $16.94 02/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1123380634 Avadel CNS Pharmaceuticals, LLC $17.00 04/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1123380636 Avadel CNS Pharmaceuticals, LLC $15.73 10/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1126072929 HARMONY BIOSCIENCES LLC $19.16 03/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1126072931 HARMONY BIOSCIENCES LLC $18.07 08/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133128077 Genentech USA, Inc. $18.21 05/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139942549 GENZYME CORPORATION $17.90 02/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139942569 GENZYME CORPORATION $16.88 05/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146895003 Philips North America LLC $16.14 07/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148326641 Axsome Therapeutics, Inc. $15.27 01/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148326643 Axsome Therapeutics, Inc. $16.56 05/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150234398 JAZZ PHARMACEUTICALS INC. $18.78 11/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.